Last reviewed · How we verify

Matching placebo to glimepiride — Competitive Intelligence Brief

Matching placebo to glimepiride (Matching placebo to glimepiride) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Diabetes.

marketed Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

Matching placebo to glimepiride (Matching placebo to glimepiride) — Merck Sharp & Dohme LLC. This is a placebo formulation designed to match the appearance and characteristics of glimepiride for use in clinical trials.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Matching placebo to glimepiride TARGET Matching placebo to glimepiride Merck Sharp & Dohme LLC marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Matching placebo to glimepiride — Competitive Intelligence Brief. https://druglandscape.com/ci/matching-placebo-to-glimepiride. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: